Patents

Methods and compositions for generating a genetically modified animal using lentiviral vectors

WO 2003059923 A2

ABSTRACT

The present invention provides methods and compositions for the integration of a nucleotide sequence of interest into the genome. Specifically, the methods of the present invention comprise contacting a lentiviral vector with the plasma membrane of an oocyte, early stage embryo, or blastula under conditions that permit the entry of the viral vector and the subsequent integration of the nucleotide sequence of interest into the genome. The methods further comprise culturing the oocyte or embryo contacted with the lentiviral vector under conditions that allow for the formation of a pre-implantation embryo.

Subsequently, the pre-implantation embryo can be transferred into a recipient vertebrate where it is allowed to develop into at least one genetically modified animal. The methods and compositions of the invention thereby allow for the production of genetically modified animals, particularly, vertebrates, and particularly mammals.

Publication number: WO2003059923 A2
Publication type: Application
Application number: PCT/US2002/041020
Publication date: Jul 24, 2003
Filing date: Dec 19, 2002
Priority date: Dec 21, 2001
Also published as: CA2470527A1, CN1633495A, EP1465981A2, EP1465981A4, US20030167500, WO2003059923A3
Inventors: Frank Koentgen, Ram Ramabhadran, John Wakefield
Applicant: Frank Koentgen, Ozgene Pty Ltd, Ram Ramabhadran, Tranzyme Inc, John Wakefield
View on Google Patents

Back to patents

Contact us

Contact us to discuss your mouse model requirements and the best solution for your project. We will provide you with an obligation free project design and quote.

Contact us now

Did you know?

Ozgene is the innovator in the C57BL/6 strain. Before founding Ozgene in 1999, Dr Frank Koentgen and Dr Gabi Suess were the first to generate and publish C57BL/6 KO mice in 1993.

Read publication

Proven Track Record

The team at Ozgene has over two decades of experience creating customised knockout and knock-in mice for pivotal medical research globally. Over 300 scientific publications are based on research using Ozgene mice.

Go to Publications

Global Client Base

Ozgene generates genetically customised mice for researchers around the world. Ozgene mice can be found in 31 different countries on 5 continents from small academic institutions to multinational pharmaceutical companies.

See Map

Lean Management

Ozgene is applying Lean Management principles to deliver the highest quality services and shortest lead times to our customers. The implementation of Lean Culture has already seen an improvement in our processes and timelines.

Read More